低分子肝素治疗新生儿败血症疗效观察

Curative effect observation of low molecular heparin in treatment of neonatal septicemia

目的探究与分析低分子肝素治疗新生儿败血症的疗效观察。方法选取本院收治的60例新生儿败血症患者,将其作为临床研究对象,采取随机数字表法分成对照组与试验组,每组均30例,对照组患儿采用传统方法进行治疗,即采用抗生素类药物,试验组患儿采用低分子肝素进行治疗,观察与比较两组患儿经不同治疗方式后的临床疗效。结果经治疗后,试验组的总有效率为90.00%,对照组为63.33%,两组比较差异具有统计学意义(P<0.05)。结论低分子肝素对于治疗新生儿败血症的临床疗效显著,且不良反应较少,具有一定的安全性,可提升患儿的生存质量,提高患儿的生存率,值得在临床范围内广泛推广。

Objective To discuss and analyze the curative effect of using low molecular heparin to treat neonatal septicemia. Methods Sixty cases of neonatal septicemia patients who had been admitted in our hospital were chosen as clinical study objectives, and were divided into control group and experimental group according to random nmnber table, each group had 30 cases, the control group patients were adopted traditional method treatment, namely adopted antibiotic drugs to them, while experimental group patients were adopted low molecular heparin as treatment, these two groups＇ patients＇ clinical curative effects after they received different treatment methods were observed and compared. Results The total effective rate was 90.00% in experimental group, which was 63.33% in control group, there was significant difference between two groups （P 〈 0.05）. Conclusion Low molecular heparin has significant clinical curative effect on the treatment of neonatal septicemia, it produces fewer adverse reactions and has certain degree of security, it can prove patients＇ life quality and survival rate, it is worthy of wide clinical promotion.